Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism.
Boeckmans J, Natale A, Rombaut M, Buyl K, Rogiers V, De Kock J, Vanhaecke T, M Rodrigues R. Boeckmans J, et al. Among authors: rombaut m. Cells. 2019 Dec 21;9(1):37. doi: 10.3390/cells9010037. Cells. 2019. PMID: 31877771 Free PMC article. Review.
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.
Boeckmans J, Natale A, Rombaut M, Buyl K, Cami B, De Boe V, Heymans A, Rogiers V, De Kock J, Vanhaecke T, Rodrigues RM. Boeckmans J, et al. Among authors: rombaut m. Cell Biol Toxicol. 2021 Apr;37(2):293-311. doi: 10.1007/s10565-020-09544-2. Epub 2020 Jul 1. Cell Biol Toxicol. 2021. PMID: 32613381
Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells.
De Kock J, Rodrigues RM, Branson S, Verhoye L, Colemonts-Vroninks H, Rombaut M, Boeckmans J, Neuckermans J, Lequeue S, Buyl K, Merimi M, Moussa Agha D, De Boe V, Lagneaux L, Meuleman P, Vanhaecke T, Najar M. De Kock J, et al. Among authors: rombaut m. Cells. 2020 Apr 8;9(4):914. doi: 10.3390/cells9040914. Cells. 2020. PMID: 32276503 Free PMC article.
Infections at the nexus of metabolic-associated fatty liver disease.
Boeckmans J, Rombaut M, Demuyser T, Declerck B, Piérard D, Rogiers V, De Kock J, Waumans L, Magerman K, Cartuyvels R, Rummens JL, Rodrigues RM, Vanhaecke T. Boeckmans J, et al. Among authors: rombaut m. Arch Toxicol. 2021 Jul;95(7):2235-2253. doi: 10.1007/s00204-021-03069-1. Epub 2021 May 24. Arch Toxicol. 2021. PMID: 34027561 Free PMC article. Review.